/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

So Yeon Oh

Hanyang University Seoul Hospital(KR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

91

Papers

644

Citations

15

h-index

21

i10-index

So Yeon Oh is an academic researcher from Hanyang University Seoul Hospital. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Gastric Cancer Management and Outcomes. The author has an h-index of 15, co-authored 78 publications.

ORCID: 0000-0002-2562-9257

Research Topics

Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations Gastric Cancer Management and Outcomes Pain Management and Opioid Use Head and Neck Cancer Studies

Papers by this author

works

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

2021 · Scientific Reports · 109 citations

https://doi.org/10.1038/s41598-021-99311-y

So Yeon Oh Soyeon Kim Bhumsuk Keam Tae Min Kim

Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients

2017 · Supportive Care in Cancer · 36 citations

https://doi.org/10.1007/s00520-017-3806-5

So Yeon Oh Sang Won Shin Su-Jin Koh Sang Byung Bae

Fully Automated Continuous Centrifugal Microfluidics Isolates Natural Killer Cells with High Performance and Minimal Stress

2023 · Analytical Chemistry · 9 citations

https://doi.org/10.1021/acs.analchem.3c01075

Sohae Yang Seung‐Hoon Kim Aseer Intisar Hyun Young Shin

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

2024 · ESMO Open · 8 citations

https://doi.org/10.1016/j.esmoop.2024.103668

Eun Joo Kang Yaewon Yang Sang-Ho Lee Yu Jung Kim

A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial)

2024 · American Journal of Hospice and Palliative Medicine® · 3 citations

https://doi.org/10.1177/10499091241252977

Kwonoh Park Jae‐Joon Kim Sang-Bo Oh So Yeon Oh

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study

2024 · Expert Opinion on Biological Therapy · 2 citations

https://doi.org/10.1080/14712598.2024.2334386

Min Ho Park Jae Hong Seo Jung Ho Park Min-Ki Seong

Research topics

topics

Colorectal Cancer Treatments and Studies

Lung Cancer Treatments and Mutations

Gastric Cancer Management and Outcomes

Pain Management and Opioid Use

Head and Neck Cancer Studies

Chat about Author

Papers

Chat

Click to start Chat